⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BFRIW News
Biofrontera Inc. Warrants
Form 8-K
sec.gov
BFRIW
BFRI
Form 8-K
sec.gov
BFRIW
BFRI
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026
globenewswire.com
BFRI
BFRIW
Form 8-K
sec.gov
BFRI
BFRIW
Form 8-K
sec.gov
BFRIW
BFRI
Form 8-K
sec.gov
BFRI
BFRIW
Form 8-K
sec.gov
BFRIW
BFRI
Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris
globenewswire.com
BFRI
BFRIW
Form 8-K
sec.gov
BFRIW
BFRI
U.S. Patent Office Issues Final Written Decision Finding All Challenged Claims of Sun Pharma’s Patent 11,697,028 To Be Unpatentable
globenewswire.com
BFRI
BFRIW